Medically reviewed by Doru Paul, MD Stage 3 lung cancer is considered locally advanced with spread in the region near the ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

We characterized CHIP and TI-CH in 421 patients with early-stage non–small-cell lung cancer (NSCLC) from the TRACERx study and in 49,351 patients from the MSK-IMPACT pan-cancer cohort.

Susan Riffle had a lesion on her lung that AI determined was likely cancer. The disease was caught at stage 1, and she avoided chemotherapy and radiation Wendy Grossman Kantor is an award-winning ...

Alecensa (alectinib) is now an option for patients with stage 1b to 3a ALK-positive NSCLC who have ... In another positive development for the lung cancer community, NICE has also given its ...

The Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center brings together experts in cardiothoracic surgery, medical oncology and radiation oncology to create personalized ...

AstraZeneca has received two separate recommendations from England’s National Institute for Health and Care Excellence (NICE) for the use of its lung cancer treatments, Tagrisso (osimertinib ...